2016 年
1. Lin SY, Matsuno Y, Yokosawa M, Suzuki T, Morishima Y, Sakamoto T, Sumida T, Hizawa N.:
Analysis of scrub typhus involvement of the lung by bronchoalveolar lavage: A case report.
Respir Investig 54(6):487-489,2016
2. Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M,Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S,Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:Effectiveness of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis.
An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia
Trial toward Sjögren's syndrome Endocrinopathy) trial.
Mod Rheumatol 26(6):891-899,2016
3. Hagiwara S, Tsuboi H, Honda F, Takahashi H, Kurata I, Ohyama A, Yagishita M, Abe S, Kurashima
Y, Kaneko S, Kawaguchi H, Takahashi H, Ebe H, Yokosawa M, Asashima H, Hirota T, Umeda N,Kondo Y, Matsumoto I, Sumida T.:
Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis.
Mod Rheumatol 26(6):857-862,2016
4. Inoue A, Matsumoto I, Tanaka Y, Umeda N, Takai C, Kawaguchi H, Ebe H, Yoshida H, Matsumoto
Y, Segawa S, Takahashi S, Sumida T.:
TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by
reducing CXCL2/CXCR2 and IL-6 expression.
Sci Rep 6:38684, 2016
5. Hachiya Y, Kawasaki A, Oka S, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A,Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M,Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H,Tsuchiya N.:
Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus ina Japanese Population: A Case-Control Association Study.
PLoS One 11(6):e0158065,2016
6. Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H,Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura
Y, Harigai M, Tsuchiya N.:
Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive
Vasculitides in a Japanese Population: A Case-Control Study.
PLoS One 11(5):e0154393,2016
7. Furukawa H, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui
N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba
N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M,Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N.:
Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent
Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.
PLoS One 11(4):e0154255,2016
8. Segawa S, Goto D, Iizuka A, Kaneko S, Yokosawa M, Kondo Y, Matsumoto I, Sumida T.:
The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17cell activity in bleomycin-induced pulmonary fibrosis.
Clin Exp Immunol 185(3):348-360,2016

9. Ohta M, Moriyama M, Maehara T, Gion Y, Furukawa S, Tanaka A, Hayashida JN, Yamauchi M,Ishiguro N, Mikami Y, Tsuboi H, Iizuka-Koga M, Kawano S, Sato Y, Kiyoshima T, Sumida T,Nakamura S.:
DNA Microarray Analysis of Submandibular Glands in IgG4-Related Disease Indicates a Role for
MARCO and Other Innate Immune-Related Proteins.
Medicine 95(7):e2853,2016
10. Sun C, Molineros JE, Looger LL, Zhou XJ, Kim K, Okada Y, Ma J, Qi YY, Kim-Howard X,Motghare P, Bhattarai K, Adler A, Bang SY, Lee HS, Kim TH, Kang YM, Suh CH, Chung WT, ParkYB, Choe JY, Shim SC, Kochi Y, Suzuki A, Kubo M, Sumida T, Yamamoto K, Lee SS, Kim YJ, Han
BG, Dozmorov M, Kaufman KM, Wren JD, Harley JB, Shen N, Chua KH, Zhang H, Bae SC, NathSK.:
High-density genotyping of immune-related loci identifies new SLE risk variants in individuals withAsian ancestry.
Nat Genet 48(3):323-330,2016
11. Nakahashi-Oda C, Udayanga KG, Nakamura Y, Nakazawa Y, Totsuka N, Miki H, Iino S, TaharaHanaoka S, Honda S, Shibuya K, Shibuya A.:
Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces.
Nature Immunol 17(4):441-450,2016
12. Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, Hirota T, Hagiwara S, Umeda
N, Kondo Y, Nishimura B, Sugano M, Matsumoto I, Sumida T.:
A case of refractory Kimura disease with a buccal bulky mass successfully treated with low-dose
cyclosporine A: report and review of the literature.
Allergol Int 65(2):212-214,2016
13. Tsuboi H, Sumida T, Noma H, Yamagishi K, Anami A, Fukushima K, Horigome H, Maeno Y,Kishimoto M, Takasaki Y, Nakayama M, Waguri M, Sago H, Murashima A.:
Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A
antibodies.
Mod Rheumatol 26(4):569-575,2016
14. Umeda N, Matsumoto I, Kawaguchi H, Kurashima Y, Kondo Y, Tsuboi H, Ogishima H, Suzuki T,Kagami Y, Sakyu T, Ishigami A, Maruyama N, Sumida T.:
Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune
diseases.
Clin Rheumatol 35(5):1181-1188,2016
15. Ikeda K, Narita A, Ogasawara M, Ohno S, Kawahito Y, Kawakami A, Ito H, Matsushita I, Suzuki T,
Misaki K, Ogura T, Kamishima T, Seto Y, Nakahara R, Kaneko A, Nakamura T, Henmi M, Fukae J,
Nishida K, Sumida T, Koike T.:
Consensus-based identification of factors related to false-positives in ultrasound scanning of synovitis
and tenosynovitis.
Mod Rheumatol 26(1):9-14,2016
16. Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, Yokosawa M, Umeda N, Kondo
Y, Tsuboi H, Matsumoto I, Sumida T.:
Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment ofrheumatoid arthritis with infliximab, tocilizumab, or abatacept.
Mod Rheumatol 26(1):29-35,2016

17. Tanaka Y, Takeuchi T, Miyasaka N, Sumida T, Mimori T, Koike T, Endo K, Mashino N, YamamotoK.:Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus
nephritis who are refractory to conventional therapy.
Mod Rheumatol 26(1):80-86,2016
18. Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V,
Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans
Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E,Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P,Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.:
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome
with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes(ESSPRI).
Ann Rheum Dis 75(2)382-389,2016